Document Detail


Catheter-based closure of atrial septal defects in the oval fossa with the Amplatzer device in patients in their first or second year of life.
MedLine Citation:
PMID:  19455678     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To assess feasibility, safety, and efficacy of the use of Amplatzer occluders in closure of atrial septal defects (ASD) in children in the first 2 years of life. BACKGROUND: Although scattered reports on such closure have been published, no agreement consists on the policy. METHODS: In 654 patients of all ages, closure was achieved in 632 (96.6%). Data were analyzed retrospectively in all 71 children where an attempt had been made to close the ASD before their second birthday. RESULTS: Median age and body weight were 17.2 months (range 3.9-23.8) and 10.0 kg (range 3.8-14.5), respectively. Median fluoroscopy time was 13.6 min and median device size 15 mm. Successful closure was achieved in 68 children (95.8%). Three times the procedure was aborted: in one, the device repeatedly straddled the septum; in the other two, a small left atrium restricted the movement of the left-sided disc. One device embolized and was reimplanted after retrieval. One infant with multiple disorders died 6 days after closure from acute sepsis probably unrelated to the procedure. No other complications occurred. Only trivial shunts closing with time were registered during follow-up. Symptomatic patients profited markedly from closure. CONCLUSION: The results and complications of ASD closure with the Amplatzer device in patients in their first 2 years of life compare favorably with procedures in older patients, provided that the size of the septum and the dimensions in the left atrium are taken into consideration when selecting the size of the device.
Authors:
G Fischer; B Smevik; H H Kramer; P G Bjørnstad
Related Documents :
11016018 - Ddd and single-lead vdd pacing: evaluation of atrial signal dynamic changes.
10359738 - Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptoma...
20346418 - Initial experience with the evolution mechanical dilator sheath for lead extraction: sa...
15848318 - Long-term outcome of right ventricular outflow tract reconstruction using a handmade tr...
24360008 - A clinical comparison of cordless and conventional displacement systems regarding clini...
25399658 - Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
Publication Detail:
Type:  Journal Article; Multicenter Study    
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  73     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-25     Completed Date:  2009-08-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  949-55     Citation Subset:  IM    
Copyright Information:
(c) 2009 Wiley-Liss, Inc.
Affiliation:
Department of Pediatric Cardiology, University Medical Center Schleswig-Holstein, Kiel, Germany. fischer@pedcard.uni-kiel.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child
Child, Preschool
Equipment Design
Feasibility Studies
Female
Germany
Heart Catheterization / adverse effects,  instrumentation*,  mortality
Heart Septal Defects, Atrial / mortality,  therapy*,  ultrasonography
Humans
Infant
Male
Norway
Patient Selection
Radiography, Interventional
Retrospective Studies
Risk Assessment
Time Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diastolic function predicts outcome after aortic valve replacement in patients with chronic severe a...
Next Document:  Three-dimensional analysis of connexin43 gap junction in the ex vivo rat seminiferous tubules: Short...